Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Uniseed is Australia's longest-running venture fund, established to assist researchers in commercializing their innovations. Founded in 2000, the firm is headquartered in Australia and collaborates with partner research organizations and UniSuper, a leading Australian superannuation fund. Uniseed's mission is to transform research ideas into marketable products and services, addressing market problems while creating community impact.
The organization has established multiple funds, including its third and largest fund launched in 2015, which received commitments from several universities and research institutions. Uniseed's approach combines financial investment with strategic support, enabling startups to navigate the complexities of bringing innovative solutions to market.
As of now, Uniseed manages a diverse portfolio of investments across various technology sectors, including biotech, healthcare, and SaaS. The firm has a strong track record of successful exits, showcasing its effectiveness in supporting the commercialization of groundbreaking research.
Uniseed invests primarily in seed-stage companies across a broad range of technology sectors, including biotech, healthcare, and SaaS. The organization provides seed capital to researchers and startups, emphasizing collaboration, expert guidance, and access to networks to de-risk innovations from both technical and commercial perspectives. This approach helps ensure that the innovations they support are not only viable but also have a clear path to market.
The investment strategy of Uniseed includes syndicating promising deals with co-investors, allowing for shared risk and enhanced support for portfolio companies. The firm looks for founders who are deeply knowledgeable about their technology and market, as well as those who demonstrate a strong commitment to their vision. Uniseed's focus on collaboration extends to its partnerships with universities and research institutions, which play a crucial role in identifying and nurturing innovative ideas.
Uniseed has invested in numerous startups, achieving notable exits that highlight its effectiveness in the venture capital space. Key exits include:
In addition to these exits, Uniseed has supported companies that have launched groundbreaking products, such as Q-Sera, which developed the RAPClot™ rapid serum blood collection tube technology, and ENA Respiratory, known for the INNA-051 nasal spray designed for viral respiratory infections. These investments reflect Uniseed's commitment to fostering innovation in critical sectors.
Alastair Hick - CEO. Alastair has extensive experience in venture capital and technology commercialization, having led numerous successful investments in the biotech sector.
Laura Droessler-Dansie - Investment Manager - Technology, Sydney. Laura specializes in technology investments and has a strong background in supporting early-stage startups.
John Kurek - Investment Director - Biotechnology, Melbourne. John brings expertise in biotechnology investments, having worked with various startups in the sector.
Aleta Knowles - Investment Manager - Biotechnology, Sydney. Aleta focuses on biotech investments and has a background in research and development.
Jeffrey Bourne - Investment Manager - Technology, Melbourne. Jeffrey has a strong track record in technology investments and supports startups in scaling their operations.
Rhiannon Black - Business Operations Specialist. Rhiannon manages operational aspects of the firm, ensuring efficient processes and support for portfolio companies.
Richard Symons - Chief Financial Officer. Richard oversees financial operations and strategy, bringing extensive experience in finance and investment management.
Alex Mahoney - Investment Analyst. Alex supports the investment team with research and analysis, contributing to the evaluation of potential investments.
In recent months, Uniseed has continued to support its portfolio companies, highlighting successful product launches and innovations. Notable activities include the launch of Q-Sera's RAPClot™ technology, which has garnered attention in the healthcare sector.
Additionally, Uniseed has been actively involved in syndicating deals with co-investors, enhancing its ability to support startups in their growth phases. The firm remains committed to fostering innovation in the biotech and healthcare sectors, as evidenced by its ongoing investments and partnerships.
What are Uniseed's investment criteria?
Uniseed focuses on seed-stage investments in technology sectors such as biotech, healthcare, and SaaS. They look for innovative ideas that address significant market problems and have the potential for community impact.
How can I pitch to Uniseed?
Founders can pitch their ideas by reaching out through Uniseed's contact page. A well-prepared pitch deck should include details about the technology, market opportunity, and the founding team’s expertise.
What makes Uniseed different from other venture funds?
Uniseed is unique due to its long-standing commitment to supporting researchers in commercializing their innovations. The firm emphasizes collaboration and provides access to a network of experts and resources that help de-risk innovations.
What is the typical check size for investments?
Uniseed typically provides seed capital, with check sizes varying based on the specific needs of the startup and the potential for growth. Exact figures may vary, but they focus on providing sufficient capital to help startups reach critical milestones.
What is Uniseed's geographic focus?
Uniseed primarily invests in Australia, collaborating closely with local universities and research institutions to identify promising innovations. However, they may consider opportunities that align with their investment thesis beyond Australia.
What kind of support do portfolio companies receive post-investment?
Uniseed offers ongoing support to its portfolio companies, including mentorship, access to networks, and assistance with scaling operations. They actively engage with founders to help navigate challenges and capitalize on growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.